Sopharma Tabex 1,5 mg (100 tablets) – LIMITED STOCK

sopharma shop

Product Filter

SKU: 90000001 Categories: ,

Sopharma Tabex 1,5 mg (100 tablets) – LIMITED STOCK







100 tablets


This batch was produced for the Russian market. However, due to the sanctions imposed, we can no longer export this batch of Tabex and we can offer the limited stock at exceptional discounts. The composition is identical to the original Bulgarian Tabex in blue boxes, only the packaging is different.


valid until end of stock

Secure Payments With

Tabex from Sopharma is a drug for the treatment of nicotine addiction. Tabex excites nicotinic receptors of the autonomic ganglia, reflexively stimulates the respiratory center, causes the release of adrenaline by the chromaffin cells of the medullary part of the adrenal glands, and increases blood pressure.

Tabex reduces nicotine addiction (associated with a competitive relationship in the area of ​​the same receptors and biochemical substrates with which nicotine interacts in the body). Tabex causes a change in the taste of smoking (making it unpleasant), reduces the craving for smoking and alleviates withdrawal symptoms associated with smoking cessation.

The mechanism of action of cytisine in Tabex is close to the mechanism of action of nicotine, which makes it possible to gradually quit smoking and at the same time prevents the development of withdrawal phenomena.


Active ingredient

cytisine 1.5 mg.


lactose monohydrate, microcrystalline cellulose, talc, magnesium stearate.

The composition of the film shell

opadry II brown (hypromellose, lactose monohydrate, titanium dioxide (E171), macrogol 3000, triacetin, iron dye yellow oxide (E172), iron dye red oxide (E172), iron dye black oxide (E172)).



  • 1-3 days – 1 tablet 6 times a day (every 2 hours). These days, a gradual reduction in the number of cigarettes smoked is expected. If the result is unsatisfactory, the treatment is stopped and can be repeated after 2-3 months. In case of satisfactory effect (significantly reduced number of cigarettes) after the 3rd day the treatment continues according to the scheme;
  • 4-12 days – 1 tablet every 2.5 hours (5 tablets daily);
  • 13-16 days – 1 tablet every 3 hours (4 tablets daily);
  • 17-20 days – 1 tablet every 5 hours (3 tablets daily);
  • 21-25 days – 1-2 tablets daily.

The final cessation of smoking should take place on the 5th day after starting treatment. At the end of the course of treatment, the patient must show will and not afford a single cigarette.

More Information


Tabex should not be used simultaneously with anti-tuberculosis drugs.


Symptoms:  nausea, vomiting, dilated pupils, general weakness, tachycardia, convulsions, respiratory paralysis.

Treatment:  gastric lavage, control of heart rate, blood pressure, respiratory function; if necessary, the introduction of infusion solutions, anticonvulsants, cardiotonic, analeptic and other symptomatic drugs.


Contraindication to the use of Tabex is:

  • acute myocardial infarction;
  • unstable angina;
  • arrhythmias;
  • recent cerebrovascular accident;
  • severe atherosclerosis;
  • bleeding from large vessels;
  • arterial hypertension;
  • pulmonary edema;
  • peptic ulcer of the stomach and duodenum (exacerbation phase);
  • bronchial asthma;
  • pregnancy;
  • lactation (breastfeeding);
  • hypersensitivity to cytisine.

With caution:  Tabex is prescribed for schizophrenia, chromaffin tumors of the adrenal glands, gastroesophageal reflux, for ischemic heart disease (including chronic heart failure), cerebrovascular diseases, hyperthyroidism, peptic ulcer of the stomach, diabetes mellitus, with renal and hepatic insufficiency. In children under 18 years of age and patients over 65 years of age, Tabex should be used after a careful assessment of the ratio of expected benefits and potential risks.


Tabex should be used only if the patient has a serious and conscious intention to stop smoking.

The patient should be warned that the use of Tabex against the background of continued smoking can lead to nicotine intoxication.

Influence on the ability to drive vehicles and other mechanisms that require increased concentration of attention

Taking Tabex does not cause changes in the psychophysical state of the patient, does not impair the ability to drive vehicles and work with mechanisms.


Tabex should be stored in a dry, dark place, out of the reach of children, at a temperature not exceeding 25°C.